The review traced the developmental history of GLP-1 research from the identification of the proglucagon gene in 1982 through to the contemporary landscape of GLP-1-based therapeutics across obesity, cardiovascular disease, NAFLD, neurodegeneration, and cancer biology
They may offer a meaningful reduction in cravings and relapse risk across various addictive disorders." Dr Sophie Dix, Head of Medical Product and Content at Levity "GLP-1s appear to modulate activity in the mesolimbic dopamine system, the same circuitry implicated in both substance addiction and compulsive overeating
The various drugs that fall into the GLP-1 agonist class are typically administered by injection on a daily or weekly basis though some medications have been developed to be taken orally
However, the triple-receptor profile is what makes Retatrutide a particularly active subject of published peer-reviewed research literature in 2026
The medication works by affecting how the body processes nutrients and manages digestive timing in several ways: Altered Nutrient Absorption: Ozempic can change how the intestines absorb nutrients, potentially leading to osmotic diarrhea when water moves into the bowels Slowed Stomach Emptying: The medication delays how quickly food leaves the stomach, which can trigger various digestive responses Gastrocolic Reflex: Ozempic can cause prolonged stomach stretching, activating what's known as the gastrocolic reflex
KovcsRHeinemannUSteinhuserC